WS #11035
Praxis Precision Medicines announced FDA extended PDUFA date for relutrigine to December 27, 2026, causing stock to fall.
Praxis Precision Medicines FDA Delay
Praxis Precision Medicines announced FDA extended PDUFA date for relutrigine to December 27, 2026, causing stock to fall.